Brain scans reveal hidden effects of Alzheimer's drug
NCT ID NCT06723015
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study uses special brain scans (tau PET) to measure how anti-amyloid therapy changes tau protein buildup in people with mild Alzheimer's disease. Researchers will track 135 adults aged 50-90 who are already receiving anti-amyloid treatment at Mayo Clinic. The goal is to better understand how these therapies affect disease progression, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.